By Nate Wolf
Publication Date: 2026-02-25 13:59:00
Oppenheimer & Co upgraded Oracle shares to “outperform” and issued a price target of $185 in a research note on Wednesday.
Buy Oracle shares, says an analyst. Here’s why.
Related Posts
Oracle to certify 350,000 executives across Egypt, Morocco in Africa and other countries – Intelligent CIO Africa
Oracle plans to train and certify 350,000 people across Egypt, Morocco, UAE, Saudi Arabia, Qatar, Jordan, in the most in-demand…
Oracle: Correction Leads to Better Buying Opportunities (NYSE:ORCL) – Seeking Alpha
Oracle: Correction Leads to Better Buying Opportunities (NYSE:ORCL) Seeking Alpha Article Source https://seekingalpha.com/article/4765629-oracle-correction-leads-better-buying-opportunities Facebook Twitter Pinterest LinkedIn Digg Tumblr Reddit Buffer…
Oracle’s Larry Ellison Says Cancer Vaccine Tailored In 48 Hours Could Soon Be A Reality As Trump Announces $500 Billion AI Investment – ARM Holdings (NASDAQ:ARM), Dell Technologies (NYSE:DELL)
Oracle Corp. ORCL co-founder Larry Ellison unveiled plans for an artificial intelligence-driven cancer vaccine system that could deliver personalized treatments…